Skip to main content
OpenTrials
Completed

NCT Number: NCT00945165

Exercise and Glycemic Control in Type 2 Diabetes

Hyperglycemia is an independent risk factor for the development of diabetic complications in type 2 diabetes. Exercise improves glycemic control, however, the role of exercise characteristics (e.g. intensity, type of exercise, timing, frequency) remains to be elucidated.

This study aims to assess the effect of several exercise characteristics on hyperglycemia in various subgroups of type 2 diabetes patiënts.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus, Type 2 Behavior Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Hyperglycemia Metabolic Diseases Motor Activity Nutritional and Metabolic Diseases

Age range

40 year–65 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Maastricht University Medical Centre

Maastricht, Limburg, 6200 MD, Netherlands

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Impaired glucose tolerant subjects

Inclusion criteria

  • BMI 25 - 35 kg/m2
  • Impaired Glucose Tolerant (according to ADA guidelines)

Exclusion criteria

  • Cardiac disease (cardiac event in the last 5 years)
  • Type 2 diabetes
  • Use of orale blood glucose lowering medication or exogenous insulin
  • HbA1c >10%

Insulin treated type 2 diabetes patients

Inclusion criteria

  • BMI 25 - 35 kg/m2
  • Insulin therapy
  • diagnosed with type 2 diabetes >2 yr

Exclusion criteria

  • Cardiac disease (cardiac event in the last 5 years)
  • HbA1c >10%

Type 2 diabetes patients on oral blood glucose lowering medication

Inclusion criteria

  • BMI 25 - 35 kg/m2
  • diagnosed with type 2 diabetes >2 yr

Exclusion criteria

  • Cardiac disease (cardiac event in the last 5 years)
  • HbA1c >10%
  • use of exogenous insulin

Treatment and study plan

Exercise Intervention

Behavioral

various exercise characteristics

No exercise

Behavioral

No exercise control period

Primary outcomes

  1. Hyperglycemia

    Time frame: 24h

Secondary outcomes

  1. Mean Blood Glucose

    Time frame: 24h

Sponsors and collaborators

Lead sponsor

Maastricht University Medical Center

Other

Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

Registry information

Official study title

Defining the Optimal Exercise Program to Improve Glycemic Control in Various Stages of Type 2 Diabetes.

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Jul 24, 2009
Registry last updated
Oct 25, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.